CEO Evan Spiegel says he wants to focus on optimizing the redesign in the …
CNBC21d
Inc. (GILD - Free Report) reported dismal results for the first quarter of 2018 wherein both earnings and revenues missed expectations due to a wider-than-expected …
Gilead Sciences gapped open sharply lower Wednesday morning and has continued to fall in early trade. Shares are now down 5.81 at $66.74 on above average volume. The stock has dropped to over a 10-month low.
The tech giant had a solid quarter and said it will raise its dividend and buy back $100 billion in stock. Gilead Sciences Inc., down $5.68 to $66.88 The company said growing competition hurt sales of its HIV drugs in the latest quarter. …
Here are some of the companies with shares expected to trade actively in Wednesday’s session. Stock movements …
May 1 (Reuters) - Gilead Sciences Inc: * GILEAD SCIENCES INC - BOARD OF DIRECTORS HAS DECLARED A …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
AbbVie Inc. (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD) are two of the world's biggest biotech stocks. However, their sales have been heading in different directions and each has offered up very different forecasts for 2018. Given that …
Gilead Sciences, Inc. (NASDAQ:GILD) has put together a nice run of late. The GILD stock price today sits 24% higher than it did as recently as June, when the stock hit a three-year low. There is some good news here. As InvestorPlace’s …